Biocon Generics acquires US facility for $7.7m, targets two billion tablet capacity

Biocon Limited, a global leader in the biopharmaceutical industry, has made a landmark announcement: its wholly-owned subsidiary, Biocon Generics Inc., has successfully acquired Eywa Pharma ... Read More